8 Folgen

Rapamycin longevity series is about increasing our knowledge about this longevity compound together with scientists, physicians and other experts.

Master One Thing - Rapamycin Longevity Series Krister Kauppi

    • Wissenschaft

Rapamycin longevity series is about increasing our knowledge about this longevity compound together with scientists, physicians and other experts.

    Joan Mannick on Rapamycin Longevity Series | Turning down mTOR to young levels may be good for aging

    Joan Mannick on Rapamycin Longevity Series | Turning down mTOR to young levels may be good for aging

    Dr Joan Mannick is one of the world’s leading rapamycin and mTOR researchers in the longevity field. Joan has a background in academic medicine and is currently CEO at her own company Tornado Therapeutics where they focus on developing the next generation of mTOR inhibitors. One of the company goals is to create a mTOR inhibitor which is better than Rapamycin. Throughout the years Joan has made important discoveries in humans when it comes to finding a connection between mTOR inhibition and improvement of the aging immune system. In this podcast we are going to talk about her research, drug development, mTOR, rapamycin, rapalogs and other interesting longevity topics.
    Links
    https://www.tornado-tx.com
    Joan's LinkedIn
    Joan’s research publications
    Big thanks to TimePie for the research help for this episode
    Rapamycin resources
    Rapamycin.news
    Rapamycin Facebook group
    Rapamycin Reddit group
    Connect with Krister on:
    Twitter
    LinkedIn
    Instagram
    Disclaimer: The podcast is for general information and educational purposes only and is not medical advice for you or others. The use of information and materials linked to the podcast is at the users own risk. Always consult your physician with anything you do regarding your health or medical condition.

    • 1 Std. 22 Min.
    Brian Kennedy on Rapamycin Master Series | Aging is the biggest risk factor for age-related diseases

    Brian Kennedy on Rapamycin Master Series | Aging is the biggest risk factor for age-related diseases

    Professor Brian Kennedy from the National University of Singapore is one of the world's leading researchers in the longevity field and has done longevity research for more than two decades. He is active in many different longevity companies and has been the President and CEO at Buck Institute for Research on Aging. Throughout the years he has made many different important and revolutionary longevity discoveries. Currently he is also one of the persons who is trying to move the longevity forward in a much efficient and faster way. This work he is doing in Singapore where he is leading a huge longevity research project. This unique project is something we are going to talk about in the podcast. We will also talk about his research on Rapamycin and other interesting longevity topics.
    Links
    The centre for Healthy Longevity at the National University of Singapore
    Healthy Longevity webinars on Youtube
    Brian's research publications
    Brian's Twitter
    Brian's LinkedIn
    Rapamycin resources
    Rapamycin.news
    Rapamycin Facebook group
    Rapamycin Reddit group
    Connect with Krister on:
    Twitter
    LinkedIn
    Instagram
    Disclaimer: The podcast is for general information and educational purposes only and is not medical advice for you or others. The use of information and materials linked to the podcast is at the users own risk. Always consult your physician with anything you do regarding your health or medical condition.

    • 1 Std. 11 Min.
    Mikhail Blagosklonny on Rapamycin Longevity Series | mTOR drives age-related diseases

    Mikhail Blagosklonny on Rapamycin Longevity Series | mTOR drives age-related diseases

    The world's leading Rapamycin researcher Mikhail Blagosklonny has a long background in cancer research and one important discovery he made around 2000 was that Rapamycin slowed down senescent cancer cells in different ways. After that step by step his interest in the longevity field increased and he developed the very interesting hyperfunction theory of aging. He has made a huge contribution in moving the Rapamycin longevity field forward and his research papers have impacted many people. For example, the Rapamycin physician Alan Green who thanks to these papers took the decision in 2017 to start prescribing Rapamycin off label. Today Alan Green has the biggest clinical experience in the area with more than 1200 patients. A lot of other physicians have after that also taken these steps and one of those are for example physician Peter Attia.
    Links
    Mikhail's research publications
    Mikhail's twitter
    Homepage
    Rapamycin resources
    Rapamycin.news
    Rapamycin Facebook group
    Rapamycin Reddit group
    Connect with Krister on:
    Twitter
    LinkedIn
    Instagram
    Disclaimer: The podcast is for general information and educational purposes only and is not medical advice for you or others. The use of information and materials linked to the podcast is at the users own risk. Always consult your physician with anything you do regarding your health or medical condition.

    • 1 Std. 42 Min.
    Brad Stanfield on Rapamycin Longevity Series | Rapamycin, mTOR and the importance of muscle in life

    Brad Stanfield on Rapamycin Longevity Series | Rapamycin, mTOR and the importance of muscle in life

    Dr Brad Stanfield works as a medical doctor in New Zealand and beside his work in primary-care he has his own Youtube channel, in which he goes through the latest research and clinical guidelines on preventative medicine and longevity. In today’s podcast we are going to talk about Brad’s upcoming Rapamycin trial, the importance of muscle when we get older, sarcopenia and lots of other interesting longevity topics.
    Links
    Brad Stanfield's Youtube
    Donate to Brad's Rapamycin clinical trial
    Brad's MicroVitamin supplement
    Brad's twitter
    Rapamycin resources
    Rapamycin.news
    Rapamycin Facebook group
    Rapamycin Reddit group
    Connect with Krister on
    Twitter
    LinkedIn
    Instagram
    Disclaimer: The podcast is for general information and educational purposes only and is not medical advice for you or others. The use of information and materials linked to the podcast is at the users own risk. Always consult your physician with anything you do regarding your health or medical condition.

    • 1 Std. 15 Min.
    Pankaj Kapahi on Rapamycin Longevity Series | There is no one size longevity intervention that fits all

    Pankaj Kapahi on Rapamycin Longevity Series | There is no one size longevity intervention that fits all

    Professor Pankaj Kapahi has his own lab at the Buck Institute for Research on Aging. His research for two decades has been focusing on things such as dietary restriction, fasting, rapamycin, nutrition and longevity. Pankaj was one of the pioneer researchers who discovered in the beginning of 2000 that genetic inhibition of mTOR led to life extension in flies. In this podcast we are going to talk about that discovery, Rapamycin, calorie restriction and other interesting longevity topics.
    Links
    Kapahi's Lab at Buck Institute
    Juvify and GLYLO
    Pankaj's twitter
    Rapamycin resources
    Rapamycin.news
    Rapamycin Facebook group
    Rapamycin Reddit group
    Connect with Krister on:
    Twitter
    LinkedIn
    Instagram
    Disclaimer: The podcast is for general information and educational purposes only and is not medical advice for you or others. The use of information and materials linked to the podcast is at the users own risk. Always consult your physician with anything you do regarding your health or medical condition.

    • 1 Std. 8 Min.
    Matt Kaeberlein on Rapamycin Longevity Series | Lessons learned from two decades of Rapamycin research

    Matt Kaeberlein on Rapamycin Longevity Series | Lessons learned from two decades of Rapamycin research

    Professor Matt Kaeberlein from the University of Washington is one of the world's leading researchers in the Rapamycin field. He has done Rapamycin research on multiple species for two decades. Everything from yeasts, worms, mice and now also dogs and humans. Matt has made a big contribution to the longevity field and in this podcast he will share the knowledge he has acquired in the field.
    Links
    The Dog Aging Project (possible to still apply)
    Ora Biomedical
    Optispan
    Matt's twitter
    Rapamycin resources
    Rapamycin.news
    Rapamycin Facebook group
    Rapamycin Reddit group
    Connect with Krister on
    Twitter
    LinkedIn

    Instagram
    Disclaimer: The podcast is for general information and educational purposes only and is not medical advice for you or others. The use of information and materials linked to the podcast is at the users own risk. Always consult your physician with anything you do regarding your health or medical condition.

    • 2 Std 28 Min.

Top‑Podcasts in Wissenschaft

Geschichten aus der Mathematik
detektor.fm – Das Podcast-Radio
Aha! Zehn Minuten Alltags-Wissen
WELT
ZEIT WISSEN. Woher weißt Du das?
ZEIT ONLINE
Das Wissen | SWR
SWR
radioWissen
Bayerischer Rundfunk
Sternengeschichten
Florian Freistetter

Das gefällt dir vielleicht auch

FoundMyFitness
Rhonda Patrick, Ph.D.
Ben Greenfield Life
Ben Greenfield
The Peter Attia Drive
Peter Attia, MD
The Human Upgrade with Dave Asprey
Dave Asprey
The Optispan Podcast with Matt Kaeberlein
Optispan
The Prof G Pod with Scott Galloway
Vox Media Podcast Network